Skip to content
Screener

Design Therapeutics, Inc. DSGN Book value per share

Book value per share at other companies

ALN
Alnylam PharmaceuticalsALNY
$9.79+410%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$5.45+179%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$18.89-11.2%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$1.38+48.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$1.05+25.7%
Vor Biopharma logo
Vor BiopharmaVOR
-$3.50-133%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$875.52M+219%
Enterprise value$865.48M+237%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Calculated from Design Therapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026. Open the filing →

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-187063

FAQ

What is Design Therapeutics, Inc.'s book value per share?
Design Therapeutics, Inc. (DSGN) reported book value per share of $3.55 in Q1 2026.
How has Design Therapeutics, Inc.'s book value per share changed year-over-year?
Design Therapeutics, Inc.'s book value per share decreased by 11.6% year-over-year, from $4.02 to $3.55.
What is the long-term trend for Design Therapeutics, Inc.'s book value per share?
Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s book value per share has grown at a 38.9% compound annual growth rate (CAGR), from -$0.72 to $3.71.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Design Therapeutics, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude